Sweden · Delayed Price · Currency is SEK Xspray Pharma AB Statistics
Total Valuation
STO:XSPRAY has a market cap or net worth of SEK 1.35 billion. The enterprise value is 1.18 billion.
| Market Cap | 1.35B |
| Enterprise Value | 1.18B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:XSPRAY has 41.74 million shares outstanding. The number of shares has increased by 12.39% in one year.
| Current Share Class | 41.74M |
| Shares Outstanding | 41.74M |
| Shares Change (YoY) | +12.39% |
| Shares Change (QoQ) | +1.63% |
| Owned by Insiders (%) | 3.97% |
| Owned by Institutions (%) | 35.75% |
| Float | 30.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 3.88 |
| PS Ratio | n/a |
| PB Ratio | 2.11 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.48 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.55 |
Financial Position
The company has a current ratio of 6.72, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.72 |
| Quick Ratio | 5.81 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.13 |
| Interest Coverage | -14.35 |
Financial Efficiency
Return on equity (ROE) is -35.27% and return on invested capital (ROIC) is -20.11%.
| Return on Equity (ROE) | -35.27% |
| Return on Assets (ROA) | -17.42% |
| Return on Invested Capital (ROIC) | -20.11% |
| Return on Capital Employed (ROCE) | -26.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -8.32M |
| Employee Count | 27 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -117,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.92% in the last 52 weeks. The beta is 0.36, so STO:XSPRAY's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -28.92% |
| 50-Day Moving Average | 31.89 |
| 200-Day Moving Average | 37.84 |
| Relative Strength Index (RSI) | 58.22 |
| Average Volume (20 Days) | 71,109 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -207.40M |
| Pretax Income | -216.54M |
| Net Income | -216.42M |
| EBITDA | -204.62M |
| EBIT | -207.40M |
| Earnings Per Share (EPS) | -5.90 |
Balance Sheet
The company has 197.98 million in cash and 28.39 million in debt, giving a net cash position of 169.60 million or 4.06 per share.
| Cash & Cash Equivalents | 197.98M |
| Total Debt | 28.39M |
| Net Cash | 169.60M |
| Net Cash Per Share | 4.06 |
| Equity (Book Value) | 641.73M |
| Book Value Per Share | 15.37 |
| Working Capital | 199.35M |
Cash Flow
In the last 12 months, operating cash flow was -213.39 million and capital expenditures -1,000, giving a free cash flow of -213.39 million.
| Operating Cash Flow | -213.39M |
| Capital Expenditures | -1,000 |
| Free Cash Flow | -213.39M |
| FCF Per Share | -5.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:XSPRAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.39% |
| Shareholder Yield | -12.39% |
| Earnings Yield | -15.98% |
| FCF Yield | -15.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |